Cubist Systematic Strategies, LLC Bio Xcel Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.49 - $11.85 $4 - $23	2 New	2 $0
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $662,884 - $1.06 Million	-59,239 Reduced 65.07%	31,800 $376,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $699,364 - $1.67 Million	77,449 Added 569.9%	91,039 $1.2 Million
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $203,850 - $310,259	13,590 New	13,590 $284,000
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $384,030 - $669,762	-19,087 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $455,034 - $611,356	19,087 New	19,087 $579,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $444,472 - $593,904	-15,295 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $597,116 - $988,056	15,295 New	15,295 $660,000
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $487,270 - $649,312	-11,476 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $429,661 - $741,693	11,476 New	11,476 $498,000
Q4 2019 Feb 14, 2020	SELL	$4.05 - $14.61 $810 - $2,922	-200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.04 - $11.77 $1,408 - $2,354	200 New	200 $1,000
Q4 2018 Feb 14, 2019	SELL	$2.41 - $7.61 $1,773 - $5,600	-736 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$7.51 - $12.99 $9,687 - $16,757	-1,290 Reduced 63.67%	736 $6,000
Q2 2018 Aug 14, 2018	BUY	$7.02 - $11.26 $14,222 - $22,812	2,026 New	2,026 $19,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.